Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Proteases of Acanthamoeba.
Mahdavi Poor B, Rashedi J, Asgharzadeh V, Mirmazhary A, Gheitarani N. Mahdavi Poor B, et al. Among authors: asgharzadeh v. Parasitol Res. 2023 Dec 8;123(1):19. doi: 10.1007/s00436-023-08059-z. Parasitol Res. 2023. PMID: 38063887 Review.
Risk Factors for COVID-19.
Rashedi J, Mahdavi Poor B, Asgharzadeh V, Pourostadi M, Samadi Kafil H, Vegari A, Tayebi-Khosroshahi H, Asgharzadeh M. Rashedi J, et al. Among authors: asgharzadeh v. Infez Med. 2020 Dec 1;28(4):469-474. Infez Med. 2020. PMID: 33257620 Free article. Review.
Why the COVID-19 Is Not Significantly Reduced in Iran?
Asgharzadeh M, Mahdavipoor B, Asgharzadeh V, Pourostadi M, Kafil HS, Vegari A, Taghinejad Z, Bairamy A, Rashedi J. Asgharzadeh M, et al. Among authors: asgharzadeh v. Iran J Public Health. 2021 Jul;50(7):1303-1310. doi: 10.18502/ijph.v50i7.6616. Iran J Public Health. 2021. PMID: 34568168 Free PMC article. Review.
The Association between Diet and Multiple Sclerosis.
Asgharzadeh V, Seyyed Rezaei SA, Poor BM, Asgharzadeh M, Nobari HJ, Taghinejad Z, Kazemi A, Rashedi J. Asgharzadeh V, et al. Endocr Metab Immune Disord Drug Targets. 2023 Nov 6. doi: 10.2174/0118715303247891231023070031. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37933212
Mixed tuberculosis infections in Northwest of Iran.
Asgharzadeh M, Taghinejad Z, Mahdavipoor B, Asgharzadeh V, Kafil HS, Rashedi J. Asgharzadeh M, et al. Among authors: asgharzadeh v. Infez Med. 2021 Dec 10;29(4):583-588. doi: 10.53854/liim-2904-12. eCollection 2021. Infez Med. 2021. PMID: 35146368 Free PMC article.
Tuberculosis and Diabetes Mellitus in Northwest of Iran.
Ozma MA, Rashedi J, Poor BM, Vegari A, Asgharzadeh V, Kafil HS, Kazemi A, Sahebi L, Asgharzadeh M. Ozma MA, et al. Among authors: asgharzadeh v. Infect Disord Drug Targets. 2020;20(5):667-671. doi: 10.2174/1871526519666190715142100. Infect Disord Drug Targets. 2020. PMID: 31322073
IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest Iran.
Asgharzadeh M, Najafi-Ghalehlou N, Poor BM, Asgharzadeh V, Pourostadi M, Vegari A, Kafil HS, Fadaee M, Farhoudi M, Rashedi J. Asgharzadeh M, et al. Among authors: asgharzadeh v. Endocr Metab Immune Disord Drug Targets. 2021;21(3):520-525. doi: 10.2174/1871530320666200505123443. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 32368988
Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran.
Asgharzadeh M, Jigheh ZA, Kafil HS, Farhoudi M, Oskouei DS, Khaki-Khatibi F, Fadaee M, Vegari A, Asgharzadeh V, Najafi-Ghalelou N, Poor BM, Rashedi J. Asgharzadeh M, et al. Among authors: asgharzadeh v. Endocr Metab Immune Disord Drug Targets. 2020;20(7):1110-1116. doi: 10.2174/1871530320666200309142541. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32148206